In order to determine if IL-10 could be suppressing DENV-specific T cell responses, we carried out ex vivo IFNγ ELISpots for NS3 and FEC in 10 of the patients with acute dengue and 4 healthy controls following blockade with anti-IL-10 and anti IL-10R antibodies. This evidence concerns the gene KRAS and dengue disease.